The best combination of bedaquiline for the treatment of drug-resistant pulmonary tuberculosis

Bedaquiline (Bedaquiline) is a drug widely used to treat drug-resistant tuberculosis. However, the optimal combination of medications may vary depending on a patient's specific circumstances. For bedaquiline + Pyrazinamide + Ethambutol (Ethambutol) This is a common triple therapy for bedaquiline-sensitive drug-resistant tuberculosis infections. Pyrazinamide and ethambutol are used to enhance treatment efficacy and reduce drug resistance.

In special circumstances, such as multidrug-resistant tuberculosis or extremely drug-resistant tuberculosis infection, the combination of bedaquiline+rifoslin (Linezolid)+aminoglycosides may be used. Rifoslin and aminoglycosides may increase the effectiveness of treatment. Andin a clinical study of patients with tuberculosis, bedaquiline, pretomanid, and pyrazinamide (bedaquiline, pretomanid, and pyrazinamide) combination therapy had better bactericidal activity. Since each patient's situation is unique, the best combination of medications should be determined based on the patient's specific situation, drug resistance test results, and physician recommendations.

The drug is marketed in China as bedaquiline fumarate tablets and has been included in the scope of medical insurance. The common specificationsThe price of 100mg*24 tablets per box may be around 10,000 yuan, which is relatively expensive. The Russian version of bedaquiline sold overseas, Specification100mg*188 tablets per box, may cost around RMB 15,000 (the price may fluctuate due to the exchange rate). The pharmaceutical ingredients of bedaquiline sold domestically and abroad are basically the same, and there are currently no generic bedaquiline drugs on the market. For specific prices and drug information of overseas drugs, please consult Yaode Medical Consultant.